Onco Neev - Blood cancer

Name

HQ

________ gene is responsible for abnormal production of WBC in Leukemia.

• Bcr- Abl

• Philadelphia tumor supressor

• Brc-Alb

• Oncogene

Multiple myeloma is cancer of _______ in bone marrow.

• WBC

• RBC

• Plasma Cells (Bone Marrow)

• Neutrophils

_________ disrupts normal homeostasis inside cell by inhibiting proteosome.

• Sunitinib

• Azacitidine

• Dasatinib

• Bortezomib

Bortetrust is indicated in _________.

• Gastric cancer

• Mantle cell lymphoma

• NSCLC

• HRPC

Dosage of Azafab in MDS is __________ daily for 7 days, followed by 3 weeks gap in 4 week cycle

• 75mg/m²

• 100mg/m²

• 175mg/m²

• 150mg/m²

Dosage of Dasapan in treatment naive PH+ ALL patient is _____

• 100mg

• 120mg

• 140mg

• 160mg

__________ is available in two strengths 50mg and 70 mg , with a packaging of 60 tablets in one bottle.

• Docetrust

• Bortetrust

• Dasapan

• Azafab

_______ is approved as first line treatment option in MM & MCL.

• Bortezomib

• Dasatinib

• Imatinib

• Docetaxel